Comparison of efficacy and toxicity between nedaplatin and cisplatin in treating malignant pleural effusion

OBJECTIVE: To evaluate the efficacy and safety of nedaplatin versus cisplatin in treating malignant pleural effusion (MPE) caused by cancers. METHODS: The clinical data of 219 MPE patients treated from January 2013 to December 2016 were retrospectively reviewed. Intrapleural infusion with nedaplatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Li-Zhe, Xu, Hong-Yan, Zhao, Zhong-Min, Zhang, Guang-Mei, Lin, Feng-Wu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134960/
https://www.ncbi.nlm.nih.gov/pubmed/30233211
http://dx.doi.org/10.2147/OTT.S168391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134960/
https://www.ncbi.nlm.nih.gov/pubmed/30233211
http://dx.doi.org/10.2147/OTT.S168391

Ejemplares similares